<prompt> CTL inducing vaccines, Recombinant Adeno-associated Virus Vaccine rAAV and Modified Vaccinia Ankara MVA are being developed forTuberculosisHIVAIDSMalariaLeprosy  <response>: Ever since 1987, more than 30 HIV candidate vaccines have been tested in Clinical trials Phases III; Some of them are: AIDSVAX gp 120 based vaccine: only vaccine in Phase III trials Cytotoxic T-Lymphocytes CTL Inducing vaccine Recombinant adeno- associated virus rAAV vaccine Modified Vaccinia ankara mVA vaccine Subunit vaccine 